Telomerase-specific oncolytic virotherapy for human gastrointestinal cancer.
about
Chapter One---Cancer terminator viruses and approaches for enhancing therapeutic outcomes.Gene Therapies for Cancer: Strategies, Challenges and Successes.Oncolytic viruses in the treatment of bladder cancerTarget expression of Staphylococcus enterotoxin A from an oncolytic adenovirus suppresses mouse bladder tumor growth and recruits CD3+ T cell.Human telomerase reverse-transcriptase promoter-controlled and herpes simplex virus thymidine kinase-armed adenoviruses for renal cell carcinoma treatment.Review: Oncolytic virotherapy, updates and future directions.
P2860
Telomerase-specific oncolytic virotherapy for human gastrointestinal cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Telomerase-specific oncolytic virotherapy for human gastrointestinal cancer.
@en
Telomerase-specific oncolytic virotherapy for human gastrointestinal cancer.
@nl
type
label
Telomerase-specific oncolytic virotherapy for human gastrointestinal cancer.
@en
Telomerase-specific oncolytic virotherapy for human gastrointestinal cancer.
@nl
prefLabel
Telomerase-specific oncolytic virotherapy for human gastrointestinal cancer.
@en
Telomerase-specific oncolytic virotherapy for human gastrointestinal cancer.
@nl
P2860
P356
P1476
Telomerase-specific oncolytic virotherapy for human gastrointestinal cancer
@en
P2093
Toshiyoshi Fujiwara
Yasuhiro Shirakawa
P2860
P304
P356
10.1586/ERA.10.200
P577
2011-04-01T00:00:00Z